NCT03188575

Brief Summary

Depression and anxiety are common mental health problems. There are effective treatments for depression and anxiety and one of these is talking therapies using cognitive behaviour therapy (CBT). In recent years CBT has been transferred to online delivery methods and these interventions have proven successful for people being treated with symptoms of depression and anxiety. The current study will utilise a randomised controlled trial design, where the majority (n=240) of participants will be allocated to the immediate treatment (internet-delivered CBT for either depression or anxiety), and a smaller number (n=120) will be allocated to a waiting list. The waiting list group will receive treatment after an eight week wait. This design helps us to understand that any changes in symptoms in the treatment group will be likely due to the treatment they received compared to the waiting list. A sample size of 360 participants is proposed and has been adjusted to ameliorate against patient dropout. Follow-up and maintenance of any positive changes in symptoms is very important in CBT for depression and anxiety, simply because some people can have a relapse of symptoms. We will therefore follow-up the treatment group for 3, 6, 9 and 12 months to assess maintenance of positive gains from treatment. The study also seeks to investigate the cost effectiveness of the treatments.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
384

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 15, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

June 15, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
Last Updated

September 10, 2018

Status Verified

September 1, 2018

Enrollment Period

2.1 years

First QC Date

June 8, 2017

Last Update Submit

September 7, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Depression symptoms

    Measured by the 9 item Patient Health Questionnaire (PHQ-9)

    Baseline, at treatment review sessions (maximum of 6 across an 8 week treatment period), 8 weeks, 3 month follow-up, 6 month follow-up, 9 month follow-up and 12 month follow-up

  • Change in Anxiety symptoms

    Measured by the 7 item Generalised Anxiety Disorder inventory (GAD-7)

    Baseline, at treatment review sessions (maximum of 6 across an 8 week treatment period), 8 weeks, 3 month follow-up, 6 month follow-up, 9 month follow-up and 12 month follow-up

Secondary Outcomes (18)

  • Work and Social Adjustment

    Baseline, at treatment review sessions (maximum of 6 across an 8 week treatment period), 8 weeks, 3 month follow-up, 6 month follow-up, 9 month follow-up and 12 month follow-up

  • Social Anxiety

    Baseline, at treatment review sessions (maximum of 6 across an 8 week treatment period), 8 weeks, 3 month follow-up, 6 month follow-up, 9 month follow-up and 12 month follow-up

  • Health Anxiety

    Baseline, at treatment review sessions (maximum of 6 across an 8 week treatment period), 8 weeks, 3 month follow-up, 6 month follow-up, 9 month follow-up and 12 month follow-up

  • Panic

    Baseline, at treatment review sessions (maximum of 6 across an 8 week treatment period), 8 weeks, 3 month follow-up, 6 month follow-up, 9 month follow-up and 12 month follow-up

  • Generalised Anxiety Symptoms

    Baseline, at treatment review sessions (maximum of 6 across an 8 week treatment period), 8 weeks, 3 month follow-up, 6 month follow-up, 9 month follow-up and 12 month follow-up

  • +13 more secondary outcomes

Study Arms (2)

iCBT for Depression and Anxiety

EXPERIMENTAL

SilverCloud Internet-Delivered Cognitive Behavioural Therapy

Behavioral: SilverCloud Internet-delivered Cognitive Behavioural Therapy

Waiting List

ACTIVE COMPARATOR

Waiting list control

Other: Waiting List

Interventions

SilverCloud Health is a leading provider of online therapeutic solutions to support and promote positive behavior change and mental wellness. SilverCloud delivers interventions for all of the anxiety disorders (panic disorder, social anxiety, phobias, GAD, health anxiety, OCD), depression and also comorbid depression and anxiety. The programs for the treatment of depression and anxiety employ several innovative engagement strategies for improving the user experience. These are divided into several categories: personal, interactive, supportive, and social. Research on the SilverCloud interventions has yielded significant clinical outcomes (Richards et al., 2015).

iCBT for Depression and Anxiety

8 week waiting list period.

Waiting List

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A score of ≥ 9 on PHQ-9 and/ or a score of ≥ 8 on GAD-7
  • years of age
  • Suitable for an internet-delivered intervention (iCBT)

You may not qualify if:

  • Suicidal intent/ideation
  • Psychotic illness
  • Currently in psychological treatment for depression and/or anxiety
  • Alcohol or drug misuse
  • Previous diagnosis of an organic mental health disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Berkshire NHS Foundation Trust

Berkshire, United Kingdom

Location

Related Publications (2)

  • Richards D, Timulak L, O'Brien E, Hayes C, Vigano N, Sharry J, Doherty G. A randomized controlled trial of an internet-delivered treatment: Its potential as a low-intensity community intervention for adults with symptoms of depression. Behav Res Ther. 2015 Dec;75:20-31. doi: 10.1016/j.brat.2015.10.005. Epub 2015 Oct 21.

    PMID: 26523885BACKGROUND
  • Richards D, Duffy D, Blackburn B, Earley C, Enrique A, Palacios J, Franklin M, Clarke G, Sollesse S, Connell S, Timulak L. Digital IAPT: the effectiveness & cost-effectiveness of internet-delivered interventions for depression and anxiety disorders in the Improving Access to Psychological Therapies programme: study protocol for a randomised control trial. BMC Psychiatry. 2018 Mar 2;18(1):59. doi: 10.1186/s12888-018-1639-5.

MeSH Terms

Conditions

DepressionAnxiety DisordersDepressive DisorderGeneralized Anxiety DisorderPhobia, SocialPhobic DisordersPanic Disorder

Interventions

Waiting Lists

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersMood Disorders

Intervention Hierarchy (Ancestors)

Appointments and SchedulesOrganization and AdministrationHealth Services Administration

Study Officials

  • Derek Richards, PhD

    SilverCloud Health

    STUDY DIRECTOR
  • Sarah Sollesse, MSc

    Berkshire Healthcare NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2017

First Posted

June 15, 2017

Study Start

June 15, 2017

Primary Completion

July 25, 2019

Study Completion

August 30, 2019

Last Updated

September 10, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Available on request from the PI

Locations